Myocarditis Clinical Trials

Find Myocarditis Clinical Trials Near You

Cardiac Manifestations of Sepsis and Its Association With Disease Outcome: A Prospective Cohort Study

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

This prospective cohort study aims to investigate the cardiac manifestations of sepsis and their influence on disease outcomes among adult patients at Jimma University Medical Center, Ethiopia, from May 2025 to May 2026. The research will include adults aged 18 and older with sepsis, categorizing them based on the presence or absence of cardiac involvement, which will be assessed through clinical symptoms, biomarkers, ECG, and echocardiographic findings. The study will evaluate the persistence of cardiac abnormalities, functional capacity, and survival over one year, utilizing structured data collection and advanced statistical methods, including survival analysis and regression techniques, to identify predictors of adverse outcomes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:

• All adult patients aged 18 years and above diagnosed with sepsis admitted to Jimma University Medical Center during the study periods that are willing to participate and continue follow-up of their disease condition for at least one year.

Locations
Other Locations
Ethiopia
Jimma University Hospital
RECRUITING
Jimma
Contact Information
Primary
Kedir Negesso Tukeni, MD, Internist, Cardiologist
Kedir.negesso@ju.edu.et
0913521475
Backup
Kidus Tesfaye Bezabih, MD, Internist
kdstesfaye@gmail.com
0920197780
Time Frame
Start Date: 2025-05-09
Estimated Completion Date: 2026-09-22
Participants
Target number of participants: 226
Treatments
Group A
This is a group of patients with the diagnosis of sepsis of any focus but without any signs/symptoms suggestive of cardiac involvement.
Group B
This is a cohort of patients with the diagnosis of sepsis of any foci and with the evidences of cardiac involvement defined as one or a combination of the following:~* Clinical symptoms include chest pain, dyspnea, or arrhythmias.~* Abnormal biomarkers, including troponins or BNP levels.~* Evidence of cardiac dysfunction on ECG or echocardiography.~Both groups will be followed prospectively for 9 to 1 year to evaluate their outcomes.
Sponsors
Leads: Jimma University
Collaborators: Ethiopian Society of Cardiac Professionals

This content was sourced from clinicaltrials.gov